Visus Therapeutics Funding: $56M Raised, Series A (2021)
Visus Therapeutics is based in Seattle, WA. It has raised $56M in total funding. Latest round: Series A.
Visus Therapeutics funding overview
Visus Therapeutics is based in Seattle, WA. Visus Therapeutics has raised $56M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in August 2021. The round record for Visus Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Johnson & Johnson Innovation – JJDC, Inc., RTW Investments, LP, Wille AG, Vision Group Canada, Planet Innovation, LSP and 1 others. 7 distinct backers are named across the disclosed rounds.
Visus Therapeutics at a glance
Total raised
$56M
Latest round
Series A
Latest round date
August 2021
Headquarters
Seattle, WA
Notable investors
Johnson & Johnson Innovation – JJDC, Inc., RTW Investments, LP, Wille AG, Vision Group Canada, Planet Innovation, LSP, Sage Partners
Frequently asked about Visus Therapeutics funding
How much has Visus Therapeutics raised?
Visus Therapeutics has raised $56M in total disclosed funding across the rounds on record.
Who has invested in Visus Therapeutics?
Johnson & Johnson Innovation – JJDC, Inc., RTW Investments, LP, Wille AG, Vision Group Canada, Planet Innovation, LSP are named among the investors backing Visus Therapeutics.
What was the latest Visus Therapeutics funding round?
The most recent disclosed round is a Series A, announced in August 2021.
Where is Visus Therapeutics based?
Visus Therapeutics is based in Seattle, WA.
When did Visus Therapeutics last raise?
The last disclosed Visus Therapeutics round closed in August 2021 at Series A.
Totals shown for Visus Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Seattle and the investors behind them below.
